Jake T. Weeks

Oct 17, 2024 | pubs.rsna.org | Vítor Martins |Tanya Wolfson |Sedighe Hosseini Shabanan |Jake T. Weeks

Abstract Imaging plays an essential role in the diagnosis, monitoring, and management of metabolic dysfunction–associated fatty liver disease, and radiology perspectives are needed to properly integrate imaging into clinical practice guidelines. Since its introduction in 1980, fatty liver disease (now termed metabolic dysfunction–associated steatotic liver disease [MASLD]) has grown in prevalence significantly, paralleling the rise of obesity worldwide.